DexCom (DXCM): Cutting PT On Temporary Market Weakness - Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Feltl & Co Downgrades Tandem Diabetes Care (TNDM) to Buy
November 2, 2016 10:52 AM EDTFeltl & Co downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Strong Buy to Buy.
For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.
Shares of Tandem Diabetes Care closed at $5.35 yesterday.
... MoreLeerink Partners Cuts Price Target on DexCom (DXCM) Following 3Q
November 2, 2016 8:29 AM EDTLeerink Partners maintained an Outperform rating on DexCom (NASDAQ: DXCM), and cut the price target to $100.00 (from $115.00), following the company's 3Q earnings report. DXCM reported revenue of $148.6M, ahead of the Streets $146.6M. Higher OpEx drove EPS below expectations.
Analyst Danielle Antalffy commented, "DXCM shares could underperform today despite a 3Q16 sales beat given: (1) The company... More
